We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
Read MoreHide Full Article
The most recent trading session ended with Oscar Health, Inc. (OSCR - Free Report) standing at $13.45, reflecting a +1.74% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of 0.64%. On the other hand, the Dow registered a gain of 0.85%, and the technology-centric Nasdaq increased by 0.31%.
Coming into today, shares of the company had lost 1.78% in the past month. In that same time, the Finance sector lost 4.63%, while the S&P 500 lost 7.69%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.83, signifying a 33.87% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.8 billion, up 30.75% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.69 per share and revenue of $11.04 billion, indicating changes of +590% and +20.34%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #3 (Hold).
With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 19.16. This expresses a premium compared to the average Forward P/E of 10.16 of its industry.
The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 64, putting it in the top 26% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
The most recent trading session ended with Oscar Health, Inc. (OSCR - Free Report) standing at $13.45, reflecting a +1.74% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of 0.64%. On the other hand, the Dow registered a gain of 0.85%, and the technology-centric Nasdaq increased by 0.31%.
Coming into today, shares of the company had lost 1.78% in the past month. In that same time, the Finance sector lost 4.63%, while the S&P 500 lost 7.69%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.83, signifying a 33.87% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.8 billion, up 30.75% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.69 per share and revenue of $11.04 billion, indicating changes of +590% and +20.34%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #3 (Hold).
With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 19.16. This expresses a premium compared to the average Forward P/E of 10.16 of its industry.
The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 64, putting it in the top 26% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.